BERNARDO TRUJILLO: Open Payments
NPI 1780132001 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 16 payments from 7 companies in 2025. Trend: 2023 $15 · 2024 $484 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $118 |
| Lilly USA, LLC | 3 | $69 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| ABBVIE INC. | 1 | $15 |
Products named: Wegovy, MOUNJARO, Ozempic, JARDIANCE, NUCALA, ZEPBOUND, ACCRUFER, FREESTYLE LIBRE.
Industry payments across FL — which companies pay providers there.
